Shattuck Labs (STTK) FCF Margin (2019 - 2025)
Shattuck Labs (STTK) posted quarterly FCF Margin of 900.0% for Q3 2025, down 36253.0% year-over-year from N/an in Q3 2024, and down 67.45% quarter-over-quarter from 537.47% in Q3 2024.
Powered by 
Analysis
Shattuck Labs (STTK) FCF Margin (2019 - 2025) Analysis & Trends
Shattuck Labs (STTK) has reported FCF Margin for 7 consecutive years, with 900.0% the latest figure, recorded in Q3 2025.
- In Q3 2025, FCF Margin fell 36253.0% year-over-year to 900.0%; the TTM figure through Mar 2026 stood at 4140.8% (down 291533.0% YoY), while the FY2025 annual figure was 3995.3%, down 293650.0% from the prior year.
- FCF Margin declined to 900.0% in Q3 2025 per STTK's latest filing, from 537.47% in the prior quarter.
- Across five years, FCF Margin topped out at 69.12% in Q4 2021 and bottomed at 46554.39% in Q1 2023.
- Historically, FCF Margin has averaged 7949.68% across 5 years, with a median of 1449.42% in 2024.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 2768141 bps — and 2024, when it surged 4510497 bps.
- Shattuck Labs' FCF Margin stood at 69.12% in 2021, then slumped by 9001 bps to 6290.77% in 2022, then jumped by 57 bps to 2722.13% in 2023, then surged by 80 bps to 537.47% in 2024, then tumbled by 67 bps to 900.0% in 2025.
- Business Quant data shows STTK's FCF Margin at 900.0% in Q3 2025, 537.47% in Q3 2024, and 679.61% in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -900.00% |
| Sep 30, 2024 | -537.47% |
| Jun 30, 2024 | -679.61% |
| Mar 31, 2024 | -1,449.42% |
| Dec 31, 2023 | -2,722.13% |
| Sep 30, 2023 | -2,441.84% |
| Jun 30, 2023 | -9,416.00% |
| Mar 31, 2023 | -46,694.74% |
| Dec 31, 2022 | -6,290.77% |
| Sep 30, 2022 | -13,591.51% |
| Jun 30, 2022 | -47,998.00% |
| Dec 31, 2021 | -69.12% |
| Sep 30, 2021 | -734.53% |
| Jun 30, 2021 | -394.07% |
| Mar 31, 2021 | -603.79% |
| Dec 31, 2020 | -1,061.40% |
| Sep 30, 2020 | -470.10% |
| Jun 30, 2020 | 58.66% |
| Mar 31, 2020 | -354.87% |
| Dec 31, 2019 | -271.04% |